{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:13:27Z","timestamp":1780380807094,"version":"3.54.1"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.det.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T08:26:15Z","timestamp":1680596775000},"page":"435-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Collagen Vascular Diseases"],"prefix":"10.1016","volume":"41","author":[{"given":"Victoria","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi","family":"Sokumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Onajin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2023.02.009_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.38238","article-title":"Population-Based Incidence and Prevalence of Systemic Lupus Erythematosus The Michigan Lupus Epidemiology and Surveillance Program","volume":"66","author":"Somers","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/art.1780380914","article-title":"Incidence of systemic lupus erythematosus. Race and gender differences","volume":"38","author":"Mccarty","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2023.02.009_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0961203310373780","article-title":"Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan","volume":"19","author":"Chiu","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib4","article-title":"Incidence and Mortality of Systemic Lupus Erythematosus in a Southern Chinese Population, 2000\u20132006","volume":"35","author":"Mok","year":"2008","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1177\/0961203319886028","article-title":"Predictors of predominant Lupus Low Disease Activity State (LLDAS-50)","volume":"28","author":"Babaoglu","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib6","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/0961203316660625","article-title":"Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa","volume":"26","author":"Lewandowski","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1177\/09612033211045284","article-title":"Health care practitioners\u2019 confidence assessing lupus-related rashes in patients of color","volume":"30","author":"Kannuthurai","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib8","article-title":"Representation of Skin Colors in Images of Patients With Lupus Erythematosus","author":"Rana","year":"2021","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.det.2023.02.009_bib9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/rheumatology\/keab809","article-title":"Racial disparities in skin tone representation of dermatomyositis rashes: a systematic review","volume":"61","author":"Babool","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.det.2023.02.009_bib10","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jisp.2016.09.001","article-title":"Not Just Skin Deep: Systemic Disease Involvement in Patients With Cutaneous Lupus","volume":"18","author":"O\u2019Brien","year":"2017","journal-title":"J\u00a0Invest Dermatol Symp Proc"},{"key":"10.1016\/j.det.2023.02.009_bib11","unstructured":"Aringer M., Costenbader K., Daikh D., et al., European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus, Ann Rheum Dis, 78, 2019, 1151\u20131159."},{"key":"10.1016\/j.det.2023.02.009_bib12","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2023.02.009_bib13","doi-asserted-by":"crossref","unstructured":"Elman S.A., Joyce C., Braudis K., et al., Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus, JAMA Dermatol, 156, 2020, 901\u2013906.","DOI":"10.1001\/jamadermatol.2020.1698"},{"key":"10.1016\/j.det.2023.02.009_bib14","doi-asserted-by":"crossref","unstructured":"Schultz H.Y., Dutz J.P., Furukawa F., et al., From Pathogenesis, Epidemiology, and Genetics to Definitions, Diagnosis, and Treatments of Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013, J Invest Dermatol, 2015, 135 7-13512, Nature Publishing Group.","DOI":"10.1038\/jid.2014.316"},{"key":"10.1016\/j.det.2023.02.009_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000085","article-title":"Redefining cutaneous lupus erythematosus: a proposed international consensus approach and results of a preliminary questionnaire","volume":"2","author":"Merola","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.det.2023.02.009_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40257-016-0173-9","article-title":"Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment","volume":"17","author":"Hejazi","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib18","doi-asserted-by":"crossref","unstructured":"Li Q., Wu H., Liao W., et al., A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus, J Autoimmun, 93, 2018, 1\u201315.","DOI":"10.1016\/j.jaut.2018.07.007"},{"key":"10.1016\/j.det.2023.02.009_bib19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0025-7125(16)30621-6","article-title":"Cutaneous lesions in systemic lupus erythematosus","volume":"73","author":"Watson","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.det.2023.02.009_bib20","doi-asserted-by":"crossref","DOI":"10.5070\/D3245040100","article-title":"Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature","volume":"24","author":"Romero","year":"2018","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2023.02.009_bib21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0961203319856091","article-title":"Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus","volume":"28","author":"Koch","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib22","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/archderm.1979.04010120007006","article-title":"Subacute Cutaneous Lupus Erythematosus: A Cutaneous Marker for a Distinct Lupus Erythematosus Subset","volume":"115","author":"Sontheimer","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib23","article-title":"Subacute Cutaneous lupus Erythematosus: A Decade\u2019s Perspective","volume":"73","author":"Sontheimer","year":"1989","journal-title":"Med Clin"},{"key":"10.1016\/j.det.2023.02.009_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.autrev.2004.10.003","article-title":"Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings","volume":"4","author":"Sontheimer","year":"2005","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"10.1016\/j.det.2023.02.009_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0560.2010.01510.x","article-title":"Histopathologic manifestations of systemic diseases: the example of cutaneous lupus erythematosus","volume":"37","author":"Sepehr","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2023.02.009_bib26","first-page":"1665","article-title":"Systemic disease in subacute cutaneous lupus erythematosus: a controlled comparison with systemic lupus erythematosus","volume":"21","author":"Cohen","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12016-017-8627-2","article-title":"The Cutaneous Spectrum of Lupus Erythematosus","volume":"53","author":"Ribero","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.det.2023.02.009_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib29","first-page":"465","article-title":"A\u00a0systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib30","first-page":"889","article-title":"Medikamenteninduzierter Lupus erythematodes unter besonderer Berucksichtigung von Hautmanifestationen und Anti-TNF\u03b1-Therapeutika","volume":"10","author":"Dalle Vedove","year":"2012","journal-title":"J\u00a0Ger Soc Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1468-3083.2008.02806.x","article-title":"Pathogenesis of subacute cutaneous lupus erythematosus","volume":"22","author":"Stavropoulos","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.02.009_bib32","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamadermatol.2013.4957","article-title":"Subacute cutaneous lupus erythematosus induced by chemotherapy: Gemcitabine as a causative agent","volume":"149","author":"Wiznia","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib33","article-title":"An update in drug-induced subacute cutaneous lupus erythematosus","volume":"23","author":"Michaelis","year":"2016","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2023.02.009_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.annder.2020.08.052","article-title":"Lupus erythematosus: Significance of dermatologic findings","volume":"148","author":"Lenormand","year":"2021","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.det.2023.02.009_bib35","doi-asserted-by":"crossref","unstructured":"Hochberg M.C., Boyd R.E., Ahearn J.M., et al., Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets, Medicine (Baltim), 64, 1985, 285\u2013295.","DOI":"10.1097\/00005792-198509000-00001"},{"key":"10.1016\/j.det.2023.02.009_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000514","article-title":"Discoid lupus erythematosus skin lesion distribution and characteristics in Black patients: a retrospective cohort study","volume":"8","author":"Joseph","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.det.2023.02.009_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn","year":"2007","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.det.2023.02.009_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archderm.1956.01550080063010","article-title":"Histopathology of cutaneous lesions in systemic lupus erythematosus","volume":"74","author":"Monthgomery","year":"1956","journal-title":"AMA Arch Derm"},{"key":"10.1016\/j.det.2023.02.009_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/art.1780230411","article-title":"The specificity and clinical usefulness of the lupus band test","volume":"23","author":"Harrist","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2023.02.009_bib40","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archderm.1978.01640170005001","article-title":"Speckled (Particulate) Epidermal Nuclear IgG Deposition in Normal Skin: Correlation of Clinical Features and Laboratory Findings in 46 Patients With a Subset of Connective Tissue Disease Characterized by Antibody to Extractable Nuclear Antigen","volume":"114","author":"Prystowsky","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib41","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/1523-1747.ep12616582","article-title":"histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus","volume":"99","author":"David-Bajar","year":"1992","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0733-8635(02)00016-5","article-title":"Cutaneous lupus erythematosus: a review","volume":"20","author":"Patel","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2023.02.009_bib43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2012.11106.x","article-title":"A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus","volume":"168","author":"Vasquez","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/bjd.12653","article-title":"The impact of skin damage due to cutaneous lupus on quality of life","volume":"170","author":"Verma","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.det.2016.02.006","article-title":"Practice and Educational Gaps in Lupus, Dermatomyositis, and Morphea","volume":"34","author":"Fett","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2023.02.009_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijwd.2020.10.008","article-title":"Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic","volume":"7","author":"Song","year":"2020","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.36849\/JDD.2020.5032","article-title":"Impact of Iron-Oxide Containing Formulations Against Visible Light-Induced Skin Pigmentation in Skin of Color Individuals","volume":"19","author":"Dumbuya","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib48","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2011.10667.x","article-title":"25-Hydroxyvitamin D levels in African-American and Caucasian\/Hispanic subjects with cutaneous lupus erythematosus","volume":"166","author":"Word","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2133.2010.09948.x","article-title":"Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year","volume":"163","author":"Heine","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib50","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/BOR.0b013e32830a991b","article-title":"Vitamin D in systemic lupus erythematosus","volume":"20","author":"Kamen","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaad.2016.02.1162","article-title":"All hairstyles are not created equal: What the dermatologist needs to know about black hairstyling practices and the risk of traction alopecia (TA)","volume":"75","author":"Haskin","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib52","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s40257-018-0363-8","article-title":"Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus","volume":"19","author":"Udompanich","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bjd.13006","article-title":"Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database","volume":"171","author":"Kuhn","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib54","first-page":"231","article-title":"Report of an association between discoid lupus erythematosus and smoking","volume":"63","author":"Gallego","year":"1999","journal-title":"Cutis"},{"key":"10.1016\/j.det.2023.02.009_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000086440","article-title":"Association between discoid lupus erythematosus and cigarette smoking","volume":"211","author":"Miot","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2023.02.009_bib56","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/jid.2011.167","article-title":"Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study","volume":"131","author":"Wahie","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archdermatol.2011.342","article-title":"Impact of smoking in cutaneous lupus erythematosus","volume":"148","author":"Piette","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib58","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaad.2014.12.025","article-title":"Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature","volume":"72","author":"Chasset","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib59","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg","year":"2016","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.det.2023.02.009_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","article-title":"Classification of myositis","volume":"14","author":"Lundberg","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.det.2023.02.009_bib62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria","volume":"180","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2018.07.006","article-title":"Connective Tissue Disease: Current Concepts","volume":"37","author":"Fernandez","year":"2019","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2023.02.009_bib64","article-title":"The Prevalence of Systemic Sclerosis, Dermatomyositis\/Polymyositis, and Giant Cell Arteritis in the United States by Race and Ethnicity: An Analysis Using Electronic Health Records [abstract]","volume":"72","author":"Goonesekera","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib65","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/art.37795","article-title":"Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004","volume":"65","author":"Feldman","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2023.02.009_bib66","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.det.2011.08.002","article-title":"Dermatologic health disparities","volume":"30","author":"Buster","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2023.02.009_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-13-103","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis","volume":"13","author":"Smoyer-Tomic","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.det.2023.02.009_bib68","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/mjd.2002.120620","article-title":"Amyopathic dermatomyositis: retrospective review of 37 cases","volume":"46","author":"El-Azhary","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jaad.2005.10.041","article-title":"A\u00a0systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies","volume":"54","author":"Gerami","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib70","first-page":"128","article-title":"The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum","volume":"31","author":"Ghazi","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/DAD.0b013e31818520e1","article-title":"Dermatomyositis: a clinicopathological study of 40 patients","volume":"31","author":"Smith","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.det.2023.02.009_bib72","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clindermatol.2018.04.003","article-title":"Dermatomyositis: Current concepts","volume":"36","author":"Bogdanov","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib73","first-page":"505","article-title":"Cutaneous signs of classical dermatomyositis","volume":"149","author":"Auriemma","year":"2014","journal-title":"G\u00a0Ital Dermatol Venereol"},{"key":"10.1016\/j.det.2023.02.009_bib74","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0002-9343(91)90222-J","article-title":"The rashes of dermatomyositis in a black patient","volume":"91","author":"Bridges","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.det.2023.02.009_bib75","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8635(02)00021-9","article-title":"Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects","volume":"20","author":"Sontheimer","year":"2002","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2023.02.009_bib76","doi-asserted-by":"crossref","unstructured":"Gordon P., Cooper R., Chinoy H., et al., AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis, Ann Rheum Dis, 75, 2016, 1119.","DOI":"10.1136\/annrheumdis-2016-eular.5174"},{"key":"10.1016\/j.det.2023.02.009_bib77","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/00002281-200311000-00006","article-title":"Skin involvement in dermatomyositis","volume":"15","author":"Santmyire-Rosenberger","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib78","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1503\/cmaj.061205","article-title":"Periorbital and facial swelling due to dermatomyositis","volume":"176","author":"Rafailidis","year":"2007","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.det.2023.02.009_bib79","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-4362.2003.01696.x","article-title":"Periorbital edema as the presenting sign of dermatomyositis","volume":"42","author":"Hall","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib80","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1067\/mjd.2000.102648","article-title":"An unusual presentation of dermatomyositis: the type Wong variant revisited","volume":"43","author":"Lupton","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib81","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/cup.12733","article-title":"Wong-type dermatomyositis: a mimic of many dermatoses","volume":"43","author":"Mutasim","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2023.02.009_bib82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2133.1969.tb16031.x","article-title":"Dermatomyositis: a clinical investigation of twenty-three cases in Hong Kong","volume":"81","author":"Wong","year":"1969","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib83","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jaad.2020.06.037","article-title":"The effects of immunostimulatory herbal supplements on autoimmune skin diseases","volume":"84","author":"Bax","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib84","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/12034754211016296","article-title":"Flagellate Dermatitis Associated With Dermatomyositis in Skin of Color","volume":"26","author":"Pangti","year":"2022","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.det.2023.02.009_bib85","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-91-4-577","article-title":"A\u00a0cutaneous lesion associated with myositis","volume":"91","author":"Stahl","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.det.2023.02.009_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/1756-0500-7-303","article-title":"Mechanic\u2019s hands revisited: is this sign still useful for diagnosis in patients with lung involvement of collagen vascular diseases?","volume":"7","author":"Sohara","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.det.2023.02.009_bib87","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/RHU.0000000000000377","article-title":"Digital Pulp Ulcerations and Inverse Gottron Papules in Melanoma Differentiation-Associated Gene 5-Related Dermatomyositis","volume":"22","author":"Ward","year":"2016","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib88","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/acr.22498","article-title":"Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease","volume":"67","author":"Narang","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.det.2023.02.009_bib89","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaad.2017.12.010","article-title":"Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features","volume":"78","author":"Kurtzman","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib90","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","article-title":"Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody","volume":"64","author":"Cao","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.det.2023.02.009_bib91","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jdcr.2022.02.031","article-title":"Prominent dyspigmentation in a patient with dermatomyositis and TIF1-\u03b3 autoantibodies","volume":"22","author":"Gutierrez","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.02.009_bib92","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1038\/jid.2013.240","article-title":"Molecular profiling to diagnose a case of atypical dermatomyositis","volume":"133","author":"Sarin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib93","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1093\/rheumatology\/keaa821","article-title":"Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis","volume":"60","author":"Rathore","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.det.2023.02.009_bib94","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-018-0733-5","article-title":"Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies","volume":"20","author":"Wolstencroft","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.det.2023.02.009_bib95","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamadermatol.2016.1429","article-title":"Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1\u03b3 (p155) Antibodies","volume":"152","author":"Bernet","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib97","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.25507","article-title":"High-resolution manometry in patients with idiopathic inflammatory myopathy: Elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset","volume":"56","author":"Casal-Dominguez","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.det.2023.02.009_bib98","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjd.18096","article-title":"Developing classification criteria for skin-predominant dermatomyositis: the Delphi process","volume":"182","author":"Concha","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib99","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0190-9622(91)70153-S","article-title":"Amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis). Presentation of six new cases and review of the literature","volume":"24","author":"Euwer","year":"1991","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib101","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis","volume":"65","author":"Goreshi","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib102","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-014-0465-0","article-title":"Amyopathic dermatomyositis: definitions, diagnosis, and management","volume":"16","author":"Bailey","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.det.2023.02.009_bib103","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjd.13167","article-title":"Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life","volume":"172","author":"Robinson","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib104","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1136\/ard.2005.045690","article-title":"Long-term outcome in polymyositis and dermatomyositis","volume":"65","author":"Bronner","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.det.2023.02.009_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijwd.2017.05.001","article-title":"The systemic management of cutaneous dermatomyositis: Results of a stepwise strategy","volume":"3","author":"Anyanwu","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib106","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaad.2017.12.074","article-title":"Dermatomyositis: A diagnostic dilemma","volume":"79","author":"da Silva","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib107","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis","volume":"37","author":"Magro","year":"2010","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2023.02.009_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2017.12.055","article-title":"Applicability of EULAR\/ACR classification criteria for dermatomyositis to amyopathic disease","volume":"79","author":"Patel","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib109","doi-asserted-by":"crossref","unstructured":"Bouaziz J.D., Barete S., Le Pelletier F., et al., Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases, Lupus, 16, 2007, 163\u2013167.","DOI":"10.1177\/0961203306075792"},{"key":"10.1016\/j.det.2023.02.009_bib110","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1177\/09612033211010329","article-title":"Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study","volume":"30","author":"Monfort","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.det.2023.02.009_bib111","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.det.2023.02.009_bib112","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","article-title":"Lupus erythematosus: systemic and cutaneous manifestations","volume":"24","author":"Rothfield","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.02.009_bib113","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1093\/rheumatology\/kez679","article-title":"Lupus versus dermatomyositis: the hands say it all","volume":"59","author":"Jain","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.det.2023.02.009_bib114","article-title":"A rare case of suspected lupus erythematous panniculitis as the presenting skin feature of juvenile dermatomyositis: A case report","volume":"10","author":"Ginter","year":"2022","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.det.2023.02.009_bib115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11926-010-0100-7","article-title":"Cutaneous manifestations of dermatomyositis and their management","volume":"12","author":"Callen","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.det.2023.02.009_bib116","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","article-title":"Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review","volume":"51","author":"Muro","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.det.2023.02.009_bib117","series-title":"Dermatomyositis. In: Dermatological signs of systemic disease","author":"Vleugels","year":"2017"},{"key":"10.1016\/j.det.2023.02.009_bib118","series-title":"Dermatomyositis. In: treatment of skin disease. Comprehensive therapeutic strategies","author":"Vleugels","year":"2014"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:46:58Z","timestamp":1760006818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863523000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0733863523000190"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.02.009","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collagen Vascular Diseases","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}